Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy

Circulation

Volumn 100, Issue 24, 1999, Pages 2449-2454

  Shimoyama, Masaki ^a   Hayashi, Doubun ^a   Takimoto, Eiki ^a   Zou, Yunzeng ^a   Oka, Toru ^a   Uozumi, Hiroki ^a   Kudoh, Sumiyo ^a   Shibasaki, Futoshi ^b   Yazaki, Yoshio ^a   Nagai, Ryozo ^c   Komuro, Issei ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c Univ of Tokyo Grad Sch of Med ^*

Author keywords

Calcineurin; Genes; Hypertrophy; Pressure

Indexed keywords

CALCINEURIN; TACROLIMUS;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA CONSTRICTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; HEART HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART VENTRICLE OVERLOAD; HEMODYNAMIC PARAMETERS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032762988     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.100.24.2449     Document Type: Article

References (35)

1. Katz AM. Cardiomyopathy of overload: a major determinant of prognosis in congestive heart failure. N Engl J Med. 1990;322:100-110.
2. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham heart study. N Engl J Med. 1990;322:1561-1566.
3. Komuro I, Yazaki Y. Control of cardiac gene expression by mechanical stress. Annu Rev Physiol. 1993;55:55-75.
4. Mann DL, Kent RL, Cooper G IV. Load regulation of the properties of adult feline cardiocytes: growth induction by cellular deformation. Circ Res. 1989;64:1079-1090.
5. Simpson P, Bishopric N, Coughlin S, Karliner J, Ordahl C, Starksen N, Tsao T, White N, Williams L. Dual trophic effects of the alpha 1-adrenergic receptor in cultured neonatal rat heart muscle cells. J Mol Cell Cardiol. 1986;18(suppl):45-58.
6. Thorburn J, Frost JA, Thorbum A. Mitogen-activated protein kinases mediate changes in gene expression, but not cytoskeletal organization associated with cardiac muscle cell hypertrophy. J Cell Biol. 1994;126: 1565-1572.
7. Sugden PH, Bogoyevitch MA. Intracellular signaling through protein kinases in the heart. Cardiovasc Res. 1995;30:478-492.
8. 1-adrenergic receptor and ras activation and is associated with in vitro and in vivo. J Biol Chem. 1997;272:14057-14061.
9. 2-terminal kinase in ventricular muscle cells. J Biol Chem. 1998;273:5423-5426.
10. Berridge MJ. Calcium signalling and cell proliferation. Bioassay. 1995; 17:491-500.
11. Molkentin JD, Lu J-R, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olson ER. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell. 1998;93:215-228.
12. Rao A, Luo C, Hogan PG. Transcriptional factors of the NFAT family: regulation and function. Annu Rev Immunol. 1997;15:707-747.
13. Sussman MA, Lim HW, Gude N, Taigen T, Olson EN, Robbins J, Colbert MC, Gualberto A, Wieczorek DF, Molkentin JD. Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science. 1998;281: 1690-1693.
14. Komuro I, Kurabayashi M, Takaku F, Yazaki Y. Expression of cellular oncogenes in the myocardium during the developmental stage and pressure-overloaded hypertrophy of the rat heart. Circ Res. 1988;62: 1075-1079.
15. 2+-activated cell death in mammalian cells. J Cell Biol. 1995;131:735-743.
16. Kojima M, Shiojima I, Yamazaki T, Komuro I, Zou Y, Wang Y, Mizuno T, Ueki K, Tobe K, Kadowaki T, Nagai R, Yazaki Y. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro. Circulation. 1994;89:2204-2211.
17. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation. 1991;83: 1849-1865.
18. Arai M, Mitsui H, Periasamy M. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. Circ Res. 1991;69:266-276.
19. Meguro T, Hong C, Asai K, Takagi G, McKinsey TA, Olson EN, Vatner SF. Cyclosporine attenuates pressure-overload hypertrophy in mice while enhancing susceptibility to decompensation and heart failure. Circ Res. 1999;84:735-740.
20. Luo Z, Shyu K-G, Gualberto A, Walsh K. Calcineurin inhibitors and cardiac hypertrophy. Nat Med. 1998;4:1092-1093.
21. Zhang W, Kowal RC, Rusnak F, Sikkink RA, Olson EN, Victor RG. Failure of calcineurin inhibitors to prevent pressure-overload left ventricular hypertrophy in rats. Circ Res. 1999;84:722-728.
22. The US Multicenter FK506 Liver Study Group. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med. 1994;331:1110-1115.
23. Liu J, Farmer JD, Lane WS, Friedman J, Weissman I, Screiber SL. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell. 1991;66:807-815.
24. Brillantes AB, Ondrias K, Scott A, Kobrinsky E, Ondriasova E, Moschella MC, Jayaraman T, Landers M, Ehrlich BE, Marks AR. Stabilization of calcium release channel (ryanodine receptor) function by FK-506 binding protein. Cell. 1994;77:513-523.
25. Timerman AP, Onoue H, Xin H-B, Barg S, Copello J, Wiederrecht G, Fleischer S. Selective binding of FKBP12.6 by the cardiac ryanodine receptor. J Biol Chem. 1996;271:20385-20391.
26. 2+ release channel closure in rat heart. J Physiol (Lond). 1997;500:343-354.
27. Sadoshima J, Xu Y, Slayter HS, Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell. 1993;75:258-265.
28. Yamazaki T, Komuro I, Kudoh S, Zou Y, Shiojima I, Hiroi Y, Mizuno T, Maemura K, Kurihara H, Aikawa R, Takano H, Yazaki Y. Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy. J Biol Chem. 1996;271:3221-3228.
29. Muller JG, Nemoto S, Laser D, Carabello BA, Merick DR. Calcineurin inhibition and cardiac hypertrophy. Science. 1998;282:1007a.
30. Ding B, Price RL, Borg TK, Weinberg EO, Halloran PF, Lorell BH. Pressure overload induces severe hypertrophy in mice treated with cyclosporine, an inhibitor of calcineurin. Circ Res. 1999;84:729-734.
31. Harada K, Komuro I, Zou Y, Kudoh S, Kijima K, Matsubara H, Sugaya T, Murakami K, Yazaki Y. Acute pressure overload could induce hypertrophic responses in the heart of angiotensin II type 1a knockout mice. Circ Res. 1998;82:779-785.
32. Pennica D, King KL, Shaw KJ, Luis E, Rullamas J, Luoh S-M, Darbonne WC, Knutzon PS, Yen R, Chien KR, Baker JB, Wood WI. Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocytes hypertrophy. Prof Natl Acad Sci USA. 1995;92:1142-1146.
33. Chin ER, Olson EN, Richardson JA, Yang Q, Humphries C, Shelton JM, Wu H, Zhu W, Bassel-Duby R, Williams RS. A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev. 1998;12:2499-2509.
34. Lin Q, Schwarz J, Bucana C, Olson EN. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science. 1997;276:1404-1407.
35. Lim HW, Molkentin JD. Calcineurin and human heart failure. Nat Med. 1999;5:246-247.